AFT Pharmaceuticals targets Chinese consumers with Crystaderm launch

AFT Pharmaceuticals targets Chinese consumers with Crystaderm launch
AFT's Chinese licensee Hainan Haiyao is doing the groundwork for its China launch. (Image: AFT)
Rebecca Stevenson
AFT Pharmaceuticals' Chinese licensee is ramping up efforts to promote its first aid cream Crystaderm to Chinese consumers. Chinese firm Hainan Haiyao Co will get its first shipment of Crystaderm at the end of this calendar year.  AFT Pharmaceuticals co-founder and managing director Dr Hartley Atkinson said the Chinese company was laying the groundwork for the product launch now. Atkinson said Shenzhen Stock Exchange-listed Hainan Haiyao had representatives meeting with doctors to raise awareness of the New Zealand produ...

More Markets

NZ sharemaket up 0.1% despite 'volatile' markets
Markets Market Close

NZ sharemaket up 0.1% despite 'volatile' markets

The S&P/NZX 50 Index closed at 12,338.57, up 18.38 points or 0.15%.

Graham Skellern 03 Apr 2025
NZX-listed companies take stock in wake of US tariff moves
Economy

NZX-listed companies take stock in wake of US tariff moves

Wine makers, manufacturers and others mull what trade wars will bring.

Ian Llewellyn 03 Apr 2025
Analysts struggle to find upside from Trump tariffs
Economy

Analysts struggle to find upside from Trump tariffs

‘They've forgotten the lessons of the Great Depression,’ one analyst said.

Gregor Thompson 03 Apr 2025
S&P/ASX200 takes a tumble on Trump's Liberation Day, Asia to follow suit
Markets

S&P/ASX200 takes a tumble on Trump's Liberation Day, Asia to follow suit

The fall may be short lived now there is more certainty. 

Rebecca Howard 03 Apr 2025